Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time.
about
Joint models for longitudinal and time-to-event data: a review of reporting quality with a view to meta-analysisMixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients.Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies.
P2860
Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Increasing chimerism after all ...... ted with longer survival time.
@ast
Increasing chimerism after all ...... ted with longer survival time.
@en
type
label
Increasing chimerism after all ...... ted with longer survival time.
@ast
Increasing chimerism after all ...... ted with longer survival time.
@en
prefLabel
Increasing chimerism after all ...... ted with longer survival time.
@ast
Increasing chimerism after all ...... ted with longer survival time.
@en
P2093
P2860
P1476
Increasing chimerism after all ...... ted with longer survival time.
@en
P2093
Borje S Andersson
Elizabeth J Shpall
Haroon Jakher
Madhushree Zope
Patricia Stafford
Peter F Thall
Richard E Champlin
Roy B Jones
Xiaowen Tang
P2860
P304
P356
10.1016/J.BBMT.2014.04.003
P577
2014-04-13T00:00:00Z